Your search for "Results" return 76 results.
The 2019 National Animal Agrobiodiversity Prize: The Bayeux Pig, Pyrenean Goat and Lapin-Chèvre Rabbit Steal the Show >
Libourne, 28 February 2019 – At the International Agricultural Show in Paris, under the patronage of the Ministry of Agriculture, Ceva Santé Animale and the Fondation du Patrimoine presented the “Fond...
Ceva announces changes to Global Manufacturing and Supply, Innovation & R&D leadership >
Changes at Executive Committee level will prepare company for next growth phase
IPPE 2019 – Ceva’s latest innovations offer producers greater performance optimisation from the hatchery >
7th February 2019, Altanta, USA - In 2019, Ceva will introduce several notable additions to its Vaccinology range of products, equipment and services drawing from the 9 Innovation Areas introduced in...
World Veterinary Association and Ceva Santé Animale honor 5 veterinarians for their exemplary work in protecting and promoting Animal Welfare. >
The 2nd WVA Animal Welfare Awards supported by Ceva puts the welfare of animals’ center stage as 5 veterinarians from Brazil, Canada, China, Senegal and Sweden are rewarded for their outstanding work...
Ceva consolidates its position as the leading French player in the global animal health market >
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
CVM and Ceva Enter Educational Partnership for Latin American Veterinarians >
The NC State College of Veterinary Medicine and animal health company Ceva are collaborating on a distance learning project in Latin America.
Opportunities to raise ethics and compliance issues >
Ceva Group employees have several internal avenues available to report actual or suspected misconduct, which satisfy their obligation under the Code to report potential ethics and compliance violation...
Ceva details latest poultry “Vaccinology” approach claiming simple vaccination is no longer enough >
At WVPA Congress, Edinburgh, the company outlines its latest innovations, in vaccines, equipment, services and quality certification
Ceva continues to deliver double-digit growth >
Sales up 20% versus S1 2016, driven by organic growth and acquisitions
Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >
7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus